Abstract Details
| Serena W. Hung, MD | Dr. Hung has received personal compensation for serving as an employee of Atalanta Therapeutics. Dr. Hung has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for LoQus23 . Dr. Hung has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for AS2 Bio. Dr. Hung has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for National Ataxia Foundation. Dr. Hung has or had stock in Atalanta Therapeutics. |
| Gholam Adeli, MD (Hamad Medical corporation) | Dr. Adeli has nothing to disclose. |
| No disclosure on file | |
| Susan Fox, MD, FÂ鶹´«Ã½Ó³» (Toronto Western Hospital) | The institution of Dr. Fox has received research support from MJFF/Safra. The institution of Dr. Fox has received research support from Parkinson Canada. The institution of Dr. Fox has received research support from NIH. Dr. Fox has received publishing royalties from a publication relating to health care. |
| Anthony E. Lang, MD, FÂ鶹´«Ã½Ó³» (Toronto Western Hospital) | Dr. Lang has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for AbbVie, Amylyx, Aprinoia, Biogen, BioAdvance, Biohaven, BioVie, BlueRock, BMS, Denali, Janssen, Lilly, Pharma 2B, Sun Pharma, and UCB. Dr. Lang has received personal compensation in the range of $50,000-$99,999 for serving as an Expert Witness for medicolegal cases related to paraquat. The institution of Dr. Lang has received research support from AbbVie. Dr. Lang has received intellectual property interests from a discovery or technology relating to health care. Dr. Lang has received publishing royalties from a publication relating to health care. |
| No disclosure on file | |
| No disclosure on file |